Current and historical price to earnings ratio for Novo Nordisk (NVO) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Novo Nordisk as of August 17, 2018 is 18.54.
|Novo Nordisk Annual PE Ratio
|Novo Nordisk Quarterly PE Ratio
||Large Cap Pharmaceutical
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.